Table 2.

Patient Characteristics and Results of Sequencing Analysis

Patient no.	Histology	Gefitinib response	EGFR activating mutations	T790M mutation
Sample 1	Contralateral lung cancer	Resistant	L858R	+
Sample 2	Primary lung cancer	Resistant	L858R	+